A focus on heme oxygenase-1 (HO-1) inhibitors.

  title={A focus on heme oxygenase-1 (HO-1) inhibitors.},
  author={V. Pittal{\`a} and L. Salerno and G. Romeo and M. Modica and M. Siracusa},
  journal={Current medicinal chemistry},
  volume={20 30},
The aim of this review is to highlight the advances in the field of heme oxygenase-1 (HO-1) inhibitors over the past years, particularly from a medicinal chemistry point of view; progresses made in the field strongly helped to clarify physiological roles of the heme oxygenase (HO) system. HO is a family of ubiquitously expressed enzymes which regulate the regiospecific catabolism of heme leading to the formation of equimolar amounts of carbon monoxide (CO), ferrous iron (Fe⁺⁺), and biliverdin… Expand
53 Citations
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application.
  • 21
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors.
  • 15
Heme oxygenase-1: emerging target of cancer therapy
  • L. Chau
  • Biology, Medicine
  • Journal of Biomedical Science
  • 2015
  • 115
  • PDF
Heme oxygenase inhibition in cancers: possible tools and targets
  • 34
  • PDF
Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.
  • 38
Differential inhibition of rat and mouse microsome heme oxygenase by derivatives of imidazole and benzimidazole.
  • PDF
Valproic acid downregulates heme oxygenase-1 independently of Nrf2 by increasing ubiquitination and proteasomal degradation.
  • 4